{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:15:10Z","timestamp":1784128510378,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04789-1","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:33:31Z","timestamp":1770197611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Collapsing FSGS in a kidney transplant with a single APOL1 risk variant: a case report"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7963-8658","authenticated-orcid":false,"given":"Emma","family":"van Schijndel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9595-6571","authenticated-orcid":false,"given":"Joris","family":"Roelofs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3712-7171","authenticated-orcid":false,"given":"Marc","family":"Hilhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4454-6270","authenticated-orcid":false,"given":"Frederike","family":"Bemelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"9","key":"4789_CR1","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1681\/ASN.2013010113","volume":"24","author":"MC Foster","year":"2013","unstructured":"Foster MC, Coresh J, Fornage M, Astor BC, Grams M, Franceschini N, et al. APOL1 variants associate with increased risk of CKD among African Americans. J Am Soc Nephrol. 2013;24(9):1484\u201391.","journal-title":"J Am Soc Nephrol"},{"issue":"23","key":"4789_CR2","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","volume":"369","author":"A Parsa","year":"2013","unstructured":"Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013;369(23):2183\u201396.","journal-title":"N Engl J Med"},{"issue":"5","key":"4789_CR3","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","volume":"11","author":"AM Reeves-Daniel","year":"2011","unstructured":"Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, et al. The APOL1 gene and allograft survival after kidney transplantation. Am J Transpl. 2011;11(5):1025\u201330.","journal-title":"Am J Transpl"},{"issue":"7","key":"4789_CR4","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1111\/j.1600-6143.2012.04033.x","volume":"12","author":"BT Lee","year":"2012","unstructured":"Lee BT, Kumar V, Williams TA, Abdi R, Bernhardy A, Dyer C, et al. The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival. Am J Transpl. 2012;12(7):1924\u20138.","journal-title":"Am J Transpl"},{"key":"4789_CR5","doi-asserted-by":"crossref","unstructured":"Zhang Z, Sun Z, Fu J, Lin Q, Banu K, Chauhan K et al. Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes. J Clin Invest. 2021;131(22).","DOI":"10.1172\/JCI146643"},{"issue":"12","key":"4789_CR6","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1097\/TP.0000000000004742","volume":"107","author":"N Roy","year":"2023","unstructured":"Roy N, Morales-Alvarez MC, Anis KH, Goral S, Doria C, Kopp JB, et al. Association of recipient APOL1 kidney risk alleles with kidney transplant outcomes. Transplantation. 2023;107(12):2575\u201380.","journal-title":"Transplantation"},{"issue":"2","key":"4789_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/snep.2003.50012","volume":"23","author":"V D\u2019Agati","year":"2003","unstructured":"D\u2019Agati V. Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol. 2003;23(2):117\u201334.","journal-title":"Semin Nephrol"},{"issue":"8","key":"4789_CR8","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1681\/ASN.2020050558","volume":"31","author":"H Wu","year":"2020","unstructured":"Wu H, Larsen CP, Hernandez-Arroyo CF, Mohamed MMB, Caza T, Sharshir M, et al. AKI and collapsing glomerulopathy associated with COVID-19 and APOL 1 High-Risk genotype. J Am Soc Nephrol. 2020;31(8):1688\u201395.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"4789_CR9","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.kint.2018.06.024","volume":"94","author":"D Santoriello","year":"2018","unstructured":"Santoriello D, Husain SA, De Serres SA, Bomback AS, Crew RJ, Vasilescu ER, et al. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de Novo collapsing glomerulopathy in renal allografts. Kidney Int. 2018;94(6):1189\u201398.","journal-title":"Kidney Int"},{"issue":"1","key":"4789_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/j.ajkd.2018.05.008","volume":"73","author":"JH Chang","year":"2019","unstructured":"Chang JH, Husain SA, Santoriello D, Stokes MB, Miles CD, Foster KW, et al. Donor\u2019s APOL1 risk genotype and second hits associated with de Novo collapsing glomerulopathy in deceased donor kidney transplant recipients: A report of 5 cases. Am J Kidney Dis. 2019;73(1):134\u20139.","journal-title":"Am J Kidney Dis"},{"key":"4789_CR11","doi-asserted-by":"crossref","unstructured":"Agha II, Simon A, Nadella S, Mahbod R. Diana; Dickerman, Richard. Living donor-derived APOL1-associated collapsing FSGS in a kidney transplant recipient. J Am Soc Nephrol. 2020.","DOI":"10.1681\/ASN.20203110S1776c"},{"issue":"6","key":"4789_CR12","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1681\/ASN.2013111242","volume":"26","author":"JB Kopp","year":"2015","unstructured":"Kopp JB, Winkler CA, Zhao X, Radeva MK, Gassman JJ, D\u2019Agati VD, et al. Clinical features and histology of Apolipoprotein L1-Associated nephropathy in the FSGS clinical trial. J Am Soc Nephrol. 2015;26(6):1443\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"4789_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/ckj\/sfx029","volume":"10","author":"L Nicholas Cossey","year":"2017","unstructured":"Nicholas Cossey L, Larsen CP, Liapis H. Collapsing glomerulopathy: a 30-year perspective and single, large center experience. Clin Kidney J. 2017;10(4):443\u20139.","journal-title":"Clin Kidney J"},{"issue":"6","key":"4789_CR14","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1111\/ajt.13748","volume":"16","author":"PB Shah","year":"2016","unstructured":"Shah PB, Cooper JE, Lucia MS, Boils C, Larsen CP, Wiseman AC. APOL1 polymorphisms in a deceased donor and early presentation of collapsing glomerulopathy and focal segmental glomerulosclerosis in two recipients. Am J Transpl. 2016;16(6):1923\u20137.","journal-title":"Am J Transpl"},{"issue":"9","key":"4789_CR15","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1016\/j.transproceed.2019.04.056","volume":"51","author":"A Mirza","year":"2019","unstructured":"Mirza A, Kowalewska J, McCune T. Transplantation with APOL1 risk variant kidney May be associated with lifetime risk for recurrence of focal segmental glomerulosclerosis: A case report and review of literature. Transpl Proc. 2019;51(9):3077\u20139.","journal-title":"Transpl Proc"},{"issue":"5","key":"4789_CR16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1053\/j.ajkd.2013.12.014","volume":"63","author":"T Kofman","year":"2014","unstructured":"Kofman T, Audard V, Narjoz C, Gribouval O, Matignon M, Leibler C, et al. APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair. Am J Kidney Dis. 2014;63(5):816\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"4789_CR17","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1097\/TXD.0000000000000697","volume":"3","author":"RS Kalil","year":"2017","unstructured":"Kalil RS, Smith RJ, Rastogi P, Katz DA, Thomas CP. Late reoccurrence of collapsing FSGS after transplantation of a Living-Related kidney bearing APOL 1 risk variants without disease evident in donor supports the second hit hypothesis. Transpl Direct. 2017;3(8):e185.","journal-title":"Transpl Direct"},{"key":"4789_CR18","doi-asserted-by":"crossref","unstructured":"Chen S, Kowalewska J, McCune TR. COVID-19 associated collapsing FSGS in an APOL1 homozygous transplant recipient after successful COVID vaccination: a case report. Transplant Proc. 2022;54(6):1543\u20136.","DOI":"10.1016\/j.transproceed.2021.11.001"},{"issue":"4","key":"4789_CR19","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1053\/j.ajkd.2020.06.009","volume":"76","author":"H Lazareth","year":"2020","unstructured":"Lazareth H, Pere H, Binois Y, Chabannes M, Schurder J, Bruneau T, et al. COVID-19-Related collapsing glomerulopathy in a kidney transplant recipient. Am J Kidney Dis. 2020;76(4):590\u20134.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"4789_CR20","doi-asserted-by":"publisher","first-page":"e14535","DOI":"10.1111\/petr.14535","volume":"27","author":"MFE Parr","year":"2023","unstructured":"Parr MFE, Hidalgo G, Goldstein MJ, Batal I, Lieberman KV, Amoruso MR, et al. CMV-associated collapsing focal segmental glomerulosclerosis after kidney transplant in a pediatric patient. Pediatr Transpl. 2023;27(5):e14535.","journal-title":"Pediatr Transpl"},{"issue":"1","key":"4789_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1681\/ASN.2020060804","volume":"32","author":"AA Shetty","year":"2021","unstructured":"Shetty AA, Tawhari I, Safar-Boueri L, Seif N, Alahmadi A, Gargiulo R, et al. COVID-19-Associated glomerular disease. J Am Soc Nephrol. 2021;32(1):33\u201340.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"4789_CR22","doi-asserted-by":"publisher","first-page":"e1325","DOI":"10.34067\/KID.0000000000000216","volume":"4","author":"J Pell","year":"2023","unstructured":"Pell J, Nagata S, Menon MC. Nonpodocyte roles of APOL1 variants: an evolving paradigm. Kidney360. 2023;4(9):e1325\u201331.","journal-title":"Kidney360"},{"key":"4789_CR23","unstructured":"Gbadegesin RA, Ulasi I, Ajayi S, Raji Y, Olanrewaju T, Osafo C et al. APOL1 Bi- and monoallelic variants and chronic kidney disease in West Africans. N Engl J Med. 2024."},{"key":"4789_CR24","doi-asserted-by":"crossref","unstructured":"Tassiopoulos KK, Wu K, Wu Z, Overton ET, Palella FJ, Wyatt C, Kalayjian RC, Bruggeman LA. APOL1 genotype and HIV infection: 20-year outcomes for CKD, cardiovascular disease, and hypertension. Kidney Int Rep. 2025;10(3).","DOI":"10.1016\/j.ekir.2024.12.022"},{"issue":"2","key":"4789_CR25","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/ki.2014.270","volume":"87","author":"B Nichols","year":"2015","unstructured":"Nichols B, Jog P, Lee JH, Blackler D, Wilmot M, D\u2019Agati V, et al. Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1. Kidney Int. 2015;87(2):332\u201342.","journal-title":"Kidney Int"},{"issue":"4","key":"4789_CR26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2215\/CJN.07311009","volume":"5","author":"GS Markowitz","year":"2010","unstructured":"Markowitz GS, Nasr SH, Stokes MB, D\u2019Agati VD. Treatment with IFN-alpha, -beta, or -gamma is associated with collapsing focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2010;5(4):607\u201315.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"4789_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1053\/j.ajkd.2019.07.010","volume":"75","author":"Q Abid","year":"2020","unstructured":"Abid Q, Best Rocha A, Larsen CP, Schulert G, Marsh R, Yasin S, et al. APOL1-Associated collapsing focal segmental glomerulosclerosis in a patient with stimulator of interferon genes (STING)-Associated vasculopathy with onset in infancy (SAVI). Am J Kidney Dis. 2020;75(2):287\u201390.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4789_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.kint.2023.03.035","volume":"104","author":"S Grampp","year":"2023","unstructured":"Grampp S, Kruger R, Lauer V, Uebel S, Knaup KX, Naas J, et al. Hypoxia hits APOL1 in the kidney. Kidney Int. 2023;104(1):53\u201360.","journal-title":"Kidney Int"},{"issue":"11","key":"4789_CR29","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1681\/ASN.0000000000000219","volume":"34","author":"AM Hung","year":"2023","unstructured":"Hung AM, Assimon VA, Chen HC, Yu Z, Vlasschaert C, Triozzi JL, et al. Genetic Inhibition of APOL1 Pore-Forming function prevents APOL1-Mediated kidney disease. J Am Soc Nephrol. 2023;34(11):1889\u201399.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"4789_CR30","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1073\/pnas.1522913113","volume":"113","author":"OA Olabisi","year":"2016","unstructured":"Olabisi OA, Zhang JY, VerPlank L, Zahler N, DiBartolo S 3rd, Heneghan JF, et al. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases. Proc Natl Acad Sci U S A. 2016;113(4):830\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"4789_CR31","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1056\/NEJMoa2202396","volume":"388","author":"O Egbuna","year":"2023","unstructured":"Egbuna O, Zimmerman B, Manos G, Fortier A, Chirieac MC, Dakin LA, et al. Inaxaplin for proteinuric kidney disease in persons with two APOL1 variants. N Engl J Med. 2023;388(11):969\u201379.","journal-title":"N Engl J Med"},{"issue":"5","key":"4789_CR32","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1681\/ASN.2013070687","volume":"25","author":"S Hakroush","year":"2014","unstructured":"Hakroush S, Cebulla A, Schaldecker T, Behr D, Mundel P, Weins A. Extensive podocyte loss triggers a rapid parietal epithelial cell response. J Am Soc Nephrol. 2014;25(5):927\u201338.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4789_CR33","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1681\/ASN.2012121180","volume":"24","author":"CP Larsen","year":"2013","unstructured":"Larsen CP, Beggs ML, Saeed M, Walker PD. Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy. J Am Soc Nephrol. 2013;24(5):722\u20135.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"4789_CR34","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/art.38220","volume":"66","author":"BI Freedman","year":"2014","unstructured":"Freedman BI, Langefeld CD, Andringa KK, Croker JA, Williams AH, Garner NE, et al. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol. 2014;66(2):390\u20136.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"4789_CR35","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1681\/ASN.2017060658","volume":"29","author":"MD Doshi","year":"2018","unstructured":"Doshi MD, Ortigosa-Goggins M, Garg AX, Li L, Poggio ED, Winkler CA, et al. APOL1 genotype and renal function of black living donors. J Am Soc Nephrol. 2018;29(4):1309\u201316.","journal-title":"J Am Soc Nephrol"},{"key":"4789_CR36","doi-asserted-by":"crossref","unstructured":"Ojo AO, Adu D, Bramham K, Freedman BI, Gbadegesin RA, Ilori TO et al. APOL1 kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2025;108(5):763\u201379.","DOI":"10.1016\/j.kint.2025.05.017"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04789-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04789-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04789-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:59:55Z","timestamp":1772794795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04789-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4789"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04789-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present work was conducted in accordance with the Declaration of Helsinki and was approved by the Medical Ethics Committee of the Amsterdam University Medical Center location AMC (number: AMC2016_045). Informed consent was obtained from the donor and family of the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained for publication of this case report from the donor and family of the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}